Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-08
1996-08-06
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514824, A61K 31495, A61K 3150
Patent
active
055434118
ABSTRACT:
This invention relates to the use of certain hydroxylated metabolites and derivatives of doxazosin and their pharmaceutically acceptable acid addition salts for retarding the development of atherosclerosis in a mammal. Such compounds are useful for reducing atherosclerotic plaque involvement and for retarding and reducing both lipid deposition fibrosis in the development of atherosclerotic plaques.
REFERENCES:
patent: 4188390 (1980-02-01), Campbell
patent: 4758569 (1988-07-01), Swindell
Hansch et al., J. Med. Chem., vol. 16, No. 11, pp. 1217-1222 (1973).
Goodman and Gilman's "The Pharmacological Basis of Therapeutics", 8th edition, edited by A. G. Gilman et al., Pergamon Press Inc., New York, 1990, chap. 1, pp. 13-14.
Lipinski, C., Annual Reports in Medicinal Chemistry, 21, chap. 27, pp. 283-291, 1986, Academic Press Inc., Dennis M. Bailey, Ed.
Ryffel et al., Transplantation Proceedings, vol. XX, No. 2, suppl. 2, pp. 575-584 (Apr. 1988).
Schlitt et al., Transplantation Proceedings, vol XIX, No. 5, pp. 4248-4251 (Oct., 1987).
Swindell Archie C.
Wong Samuel S.
DeBenedictis Karen
Ginsburg Paul H.
Jordan Kimberly
Pfizer Inc.
Richardson Peter C.
LandOfFree
Hydroxylated metabolites and derivatives of doxazosin as anti-at does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxylated metabolites and derivatives of doxazosin as anti-at, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxylated metabolites and derivatives of doxazosin as anti-at will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191229